All Phage Therapy articles – Page 5
-
CareersPhage against the dying of the light - bacteriophages have been sparking a buzz for over a century now
Tom Ireland’s latest book The Good Virus reveals the rollercoaster history of bacteriophages - and why these prolific entities could offer fresh hope in a time of surging antimicrobial resistance.
-
NewsTeam find promising bacterial suicide gene against citrus Huanglongbing and canker
Researchers have found that an endolysin encoded by the CaLas prophage has dual resistance to Huanglongbing and citrus canker.
-
NewsParasites of viruses drive superbug evolution
Researchers have discovered a previously unknown mechanism by which bacteria share their genetic material through virus parasites.
-
FeaturesAntimicrobial resistance and phage therapy in India
The story that led to the formation of Vitalis Phage Therapy - the first of its kind initiative to establish frameworks for phage therapy in India.
-
OpinionDoes the world need another antibiotic?
Barriers, opportunities and alternatives in the fight against AMR.
-
NewsThe Phage-Microbiome Consortium is launched
The International Society of Microbiota (ISM) has announced the launch of a new initiative: The Phage-Microbiome Consortium.
-
NewsEavesdropping viruses wait for bacterial signals before switching to kill mode
Researchers have found that dozens of viruses respond to quorum sensing or other chemical signals from bacteria.
-
NewsRapid test for cystitis deploys phages to destroy pathogens
Scientists have developed a rapid test that employs the natural viral predators of bacteria, bacteriophages. The researchers also genetically modified the phages to make them more efficient at destroying the pathogenic bacteria.
-
NewsBiotech spinoff PHIOGEN to tackle threat of antimicrobial resistance
A new biotech spin-off, PHIOGEN, has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections.
-
NewsDrugs pipeline rife with strategies to combat MRSA
A host of new antimicrobial strategies are in the development pipeline that could provide hope for healthcare sectors battling multi-drug resistant Staphylococcus aureus infections.
-
NewsPublic embrace phages as antibiotic alternative
The public are in favour of the development of bacteria-killing viruses as an alternative to antibiotics – and more efforts to educate will make them significantly more likely to use the treatment, a new study shows.
-
NewsFilamentous phage structure mapped for the first time
Researchers have mapped out what a commonly-used form of phage looks like, which will help researchers design better uses in future.
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.
-
NewsPhage delivers double whammy against biofilms
A novel bacteriophage isolated from sewage water not only kills its target bacteria in the Klebsiella oxytoca complex but was unexpectedly found to be capable of disrupting biofilms produced by these bacteria.
-
NewsPolymer discovery stops bacterial virus contamination
A new discovery by researchers at the University of Warwick could help stop bacteria being contaminated with viruses, reducing disruption and decreasing costs in industry and research.
-
CareersDoing something scary every week
Professor James Ebdon’s experience of pitching bacteriophages to the Commons Science and Technology Committee.
-
NewsScreening tool pinpoints phages with best potential as antibiotics
A new screening tool circumvents the difficulty of studying individual bacteriophage proteins and determining precisely how the virus wields these tools to kill their host bacteria.
-
NewsHarmful bacteria can elude predators when concealed in mixed colonies
Efforts to fight disease-causing bacteria by harnessing their natural predators could be undermined when multiple species occupy the same space, a new study has revealed.
-
NewsRegulatory pathway needs to be developed to make the most of phages: AMI
A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage of the potential of phage therapeutics, while bacteriophages - viruses that are capable of destroying ...
-
NewsNew leaf: AMI’s PhD studentship winner Naina Korotania talks trees and phages
Naina Korotania, winner of the Basil Jarvis PhD Studentship, which is awarded by Applied Microbiology International, is poised to embark on a PhD at the Univeristy of Birmingham, developing novel phage-based biopesticides to target cankers in four tree species.
